Cultural and Digital Health Literacy Appropriateness of App- and Web-Based Systems Designed for Pregnant Women With Gestational Diabetes Mellitus: Scoping Review.
culture
gestational diabetes mellitus
health literacy
mHealth
maternal health
mobile apps
mobile health
mobile phone
pregnancy outcome
telemedicine
vulnerable populations
Journal
Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882
Informations de publication
Date de publication:
14 10 2022
14 10 2022
Historique:
received:
13
03
2022
accepted:
31
07
2022
revised:
03
07
2022
entrez:
14
10
2022
pubmed:
15
10
2022
medline:
19
10
2022
Statut:
epublish
Résumé
The prevalence of women diagnosed with gestational diabetes mellitus (GDM) is increasing dramatically. Mobile technologies to enhance patient self-management offer many advantages for women diagnosed with GDM. However, to our knowledge, although mobile health (mHealth) and telemedicine systems for GDM management exist, evidence on their cultural and digital health literacy appropriateness levels is limited. This review aimed to search and assess the literature on mHealth and telemedicine systems designed for women diagnosed with GDM. Our assessment of these technologies focused on their cultural and digital health literacy appropriateness as well as the systems' effectiveness in improving glycemic control and maternal and infant outcomes. We conducted a scoping review using a framework adapted from Arksey and O'Malley. Four electronic databases were searched for relevant studies: PubMed, MEDLINE (EBSCO), Web of Science, and Scopus. The databases were searched between January 2010 and January 2022. The inclusion criteria were pregnant women diagnosed with GDM, use of telemedicine for monitoring and management, and vulnerable or disadvantaged patients. We used terms related to mobile apps and telemedicine: GDM, vulnerable populations, periphery, cultural appropriateness, and digital health literacy. Studies were screened and selected independently by 2 authors. We extracted the study data on a Microsoft Excel charting table and categorized them into final themes. The results were categorized according to the cultural and digital health literacy features presented. We identified 17 studies that reported on 12 telemedicine and mHealth app interventions. We assessed the studies in three domains: cultural appropriateness, digital health literacy, and maternal and infant outcomes. In the literature, we found that existing digital technologies may improve glycemic control and diabetes self-management. However, there is a lack of assessment of cultural and digital health literacy appropriateness for pregnant women diagnosed with GDM. Considerations in app design regarding cultural appropriateness were found in only 12% (2/17) of the studies, and only 25% (3/12) of the interventions scored ≥3 out of 5 in our assessment of digital health literacy. mHealth and telemedicine can be an effective platform to improve the clinical management of women with GDM. Although studies published on the use of mHealth and telemedicine systems exist, there is a limited body of knowledge on the digital health literacy and cultural appropriateness of the systems designed for women diagnosed with GDM. In addition, as our study was restricted to the English language, relevant studies may have been excluded. Further research is needed to evaluate, design, and implement better tailored apps regarding cultural and digital literacy appropriateness for enhancing pregnant women's self-management as well as the effectiveness of these apps in improving maternal and infant health outcomes.
Sections du résumé
BACKGROUND
The prevalence of women diagnosed with gestational diabetes mellitus (GDM) is increasing dramatically. Mobile technologies to enhance patient self-management offer many advantages for women diagnosed with GDM. However, to our knowledge, although mobile health (mHealth) and telemedicine systems for GDM management exist, evidence on their cultural and digital health literacy appropriateness levels is limited.
OBJECTIVE
This review aimed to search and assess the literature on mHealth and telemedicine systems designed for women diagnosed with GDM. Our assessment of these technologies focused on their cultural and digital health literacy appropriateness as well as the systems' effectiveness in improving glycemic control and maternal and infant outcomes.
METHODS
We conducted a scoping review using a framework adapted from Arksey and O'Malley. Four electronic databases were searched for relevant studies: PubMed, MEDLINE (EBSCO), Web of Science, and Scopus. The databases were searched between January 2010 and January 2022. The inclusion criteria were pregnant women diagnosed with GDM, use of telemedicine for monitoring and management, and vulnerable or disadvantaged patients. We used terms related to mobile apps and telemedicine: GDM, vulnerable populations, periphery, cultural appropriateness, and digital health literacy. Studies were screened and selected independently by 2 authors. We extracted the study data on a Microsoft Excel charting table and categorized them into final themes. The results were categorized according to the cultural and digital health literacy features presented.
RESULTS
We identified 17 studies that reported on 12 telemedicine and mHealth app interventions. We assessed the studies in three domains: cultural appropriateness, digital health literacy, and maternal and infant outcomes. In the literature, we found that existing digital technologies may improve glycemic control and diabetes self-management. However, there is a lack of assessment of cultural and digital health literacy appropriateness for pregnant women diagnosed with GDM. Considerations in app design regarding cultural appropriateness were found in only 12% (2/17) of the studies, and only 25% (3/12) of the interventions scored ≥3 out of 5 in our assessment of digital health literacy.
CONCLUSIONS
mHealth and telemedicine can be an effective platform to improve the clinical management of women with GDM. Although studies published on the use of mHealth and telemedicine systems exist, there is a limited body of knowledge on the digital health literacy and cultural appropriateness of the systems designed for women diagnosed with GDM. In addition, as our study was restricted to the English language, relevant studies may have been excluded. Further research is needed to evaluate, design, and implement better tailored apps regarding cultural and digital literacy appropriateness for enhancing pregnant women's self-management as well as the effectiveness of these apps in improving maternal and infant health outcomes.
Identifiants
pubmed: 36240008
pii: v24i10e37844
doi: 10.2196/37844
pmc: PMC9617190
doi:
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e37844Informations de copyright
©Yosefa Birati, Enav Yefet, Yuri Perlitz, Naim Shehadeh, Sivan Spitzer. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 14.10.2022.
Références
J Clin Nurs. 2014 May;23(9-10):1374-84
pubmed: 24313229
J Obstet Gynaecol. 2017 Aug;37(6):691-699
pubmed: 28467229
JMIR Mhealth Uhealth. 2018 Mar 20;6(3):e71
pubmed: 29559428
J Acad Nutr Diet. 2018 Sep;118(9):1719-1742
pubmed: 29859757
BMJ Open. 2019 Nov 11;9(11):e030884
pubmed: 31719080
Healthcare (Basel). 2015 May 21;3(2):310-23
pubmed: 27417764
J Gen Intern Med. 2019 Jun;34(6):1007-1017
pubmed: 30877457
Int J Med Inform. 2017 Jun;102:35-49
pubmed: 28495347
Diabetes Res Clin Pract. 2020 Nov;169:108396
pubmed: 32890548
Obstet Gynecol Clin North Am. 2018 Jun;45(2):299-314
pubmed: 29747732
J Obstet Gynaecol Res. 2018 Jul;44(7):1228-1234
pubmed: 29797375
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
J Med Internet Res. 2018 May 10;20(5):e178
pubmed: 29748163
Indian J Endocrinol Metab. 2016 Jul-Aug;20(4):481-90
pubmed: 27366714
J Endocrinol Invest. 2019 Jun;42(6):709-714
pubmed: 30406378
Diabetes Care. 2021 Feb;44(2):456-463
pubmed: 33184151
JMIR Mhealth Uhealth. 2021 May 25;9(5):e22881
pubmed: 33783365
Am J Obstet Gynecol. 2018 Apr;218(4):453.e1-453.e7
pubmed: 29425836
Ann Nutr Metab. 2015;66 Suppl 2:14-20
pubmed: 26045324
J Med Internet Res. 2006 Jun 16;8(2):e9
pubmed: 16867972
J Obstet Gynecol Neonatal Nurs. 2018 Nov;47(6):830-832
pubmed: 30292776
BMC Pregnancy Childbirth. 2018 Jan 11;18(1):25
pubmed: 29325518
Int J Endocrinol. 2010;2010:386941
pubmed: 20628517
Diabetes Res Clin Pract. 2018 Aug;142:276-285
pubmed: 29885390
Midwifery. 2018 Mar;58:102-108
pubmed: 29329023
JMIR Diabetes. 2017 Oct 04;2(2):e25
pubmed: 30291088
JMIR Mhealth Uhealth. 2020 Nov 4;8(11):e18614
pubmed: 33146620
Obstet Gynecol Surv. 2021 Jun;76(6):367-381
pubmed: 34192341
Lancet Diabetes Endocrinol. 2020 Sep;8(9):793-800
pubmed: 32822601
BMC Pregnancy Childbirth. 2020 Feb 7;20(1):76
pubmed: 32028931
Int J Environ Res Public Health. 2021 Jun 21;18(12):
pubmed: 34205744
Endocrinol Nutr. 2013 Oct;60(8):441-6
pubmed: 23731804
J Diabetes Sci Technol. 2014 Nov;8(6):1105-14
pubmed: 25004915
Cell Biochem Biophys. 2015 Mar;71(2):689-94
pubmed: 25269773
Diabetes Technol Ther. 2012 Jul;14(7):624-9
pubmed: 22512287
Aust N Z J Obstet Gynaecol. 2019 Apr;59(2):215-220
pubmed: 29718540
Implement Sci. 2010 Sep 20;5:69
pubmed: 20854677
JMIR Mhealth Uhealth. 2021 Feb 5;9(2):e18404
pubmed: 33544088
Rural Remote Health. 2021 Jan;21(1):5983
pubmed: 33478229
BMJ Open. 2016 Mar 17;6(3):e009702
pubmed: 26988348
JMIR Diabetes. 2019 Nov 28;4(4):e13661
pubmed: 31778118
JMIR Mhealth Uhealth. 2018 May 14;6(5):e123
pubmed: 29759959
Stud Health Technol Inform. 2017;240:347-355
pubmed: 28972527
JMIR Mhealth Uhealth. 2018 Nov 16;6(11):e189
pubmed: 30446483
Diabetes Technol Ther. 2015 May;17(5):349-54
pubmed: 25629547
JMIR Res Protoc. 2016 Aug 09;5(3):e163
pubmed: 27507708
Diabetes Technol Ther. 2007 Jun;9(3):297-306
pubmed: 17561800
Diabetes Res Clin Pract. 2010 Feb;87(2):e15-7
pubmed: 20044162
J Clin Med. 2018 May 28;7(6):
pubmed: 29843401